Tapia, Milagritos D
Sow, Samba O
Lyke, Kirsten E
Haidara, Fadima Cheick
Diallo, Fatoumata
Doumbia, Moussa
Traore, Awa
Coulibaly, Flanon
Kodio, Mamoudou
Onwuchekwa, Uma
Sztein, Marcelo B
Wahid, Rezwanul
Campbell, James D
Kieny, Marie-Paule
Moorthy, Vasee
Imoukhuede, Egeruan B
Rampling, Tommy
Roman, Francois
De Ryck, Iris
Bellamy, Abbie R
Dally, Len
Mbaya, Olivier Tshiani
Ploquin, Aurélie
Zhou, Yan
Stanley, Daphne A
Bailer, Robert
Koup, Richard A
Roederer, Mario
Ledgerwood, Julie
Hill, Adrian V S
Ballou, W Ripley
Sullivan, Nancy
Graham, Barney
Levine, Myron M
This article is maintained by: Elsevier
Article Title: Use of ChAd3-EBO-Z Ebola virus vaccine in Malian and US adults, and boosting of Malian adults with MVA-BN-Filo: a phase 1, single-blind, randomised trial, a phase 1b, open-label and double-blind, dose-escalation trial, and a nested, randomised, double-blind, placebo-controlled trial
Journal Title: The Lancet Infectious Diseases
CrossRef DOI link to publisher maintained version: https://doi.org/10.1016/S1473-3099(15)00362-X
CrossRef DOI link to the associated document: https://doi.org/10.1016/S1473-3099(15)00408-9
Content Type: article
Copyright: Copyright © 2016 Tapia et al. Open Access article distributed under the terms of CC BY. Published by Elsevier Ltd.